PHARMAMEDICINE CONSULTING LTD

(Company Number 10066452)

Registered office: Lynton House, 7-12 Tavistock Square, London, WC1H 9LT

Principal trading address: 7 Dalmeny Road, Carshalton SM5 4PL

Notice is hereby given pursuant to Rule 14.28 of the Insolvency (England and Wales) Rules 2016, by Laurence Pagden (IP No. 9055) and Jonathan Bass (IP No. 11790) both of Menzies LLP, Lynton House, 7-12 Tavistock Square, London, WC1H 9LT the Joint Liquidators, to the creditors of Pharmamedicine Consulting Ltd, that we intend declaring a first and final dividend to the unsecured creditors within two months of the last date for proving specified below.

Every person claiming to be a creditor of the Company is required on or before 30 June 2021, which is the last date for proving, to submit a proof of debt to us at Menzies LLP, Lynton House, 7-12 Tavistock Square, London, WC1H 9LT and, if so requested by us, to provide such further details or produce such documentary or other evidence as may appear to be necessary.

A creditor who has not proved his debt before the last date for proving mentioned above is not entitled to disturb, by reason that he has not participated in the dividend, the distribution of that dividend or any other dividend declared before his debt is proved. The winding up of the Company is a members' voluntary winding up. The distribution proposed to be made is to be the final distribution in the winding up of the above named Company and, accordingly, the Joint Liquidators may make the distribution without regard to the claim of any person in respect of a debt not already proved.

Date of Appointment: 1 April 2021

Contact details for Liquidators: Maisie Jones, Tel: 020 7465 1921; Email: MJones@menzies.co.uk

Laurence Pagden, Joint Liquidator

7 April 2021

Ag DH10365